GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,540,000 | +506.7% | 565,940 | +184.7% | 0.01% | +400.0% |
| Q2 2022 | $6,352,000 | +13.3% | 198,772 | +22.9% | 0.00% | +100.0% |
| Q1 2022 | $5,604,000 | -61.9% | 161,755 | -67.8% | 0.00% | – |
| Q4 2021 | $14,706,000 | +57.5% | 502,384 | +37.1% | 0.00% | -100.0% |
| Q3 2021 | $9,335,000 | -9.9% | 366,385 | +23.9% | 0.00% | 0.0% |
| Q2 2021 | $10,355,000 | -39.2% | 295,704 | -29.2% | 0.00% | -66.7% |
| Q1 2021 | $17,026,000 | -60.7% | 417,828 | -58.2% | 0.00% | -25.0% |
| Q4 2020 | $43,314,000 | +61.4% | 1,000,138 | +105.4% | 0.00% | -20.0% |
| Q3 2020 | $26,844,000 | -8.2% | 486,820 | +5.1% | 0.01% | -37.5% |
| Q2 2020 | $29,253,000 | -0.9% | 463,381 | -19.8% | 0.01% | -20.0% |
| Q1 2020 | $29,507,000 | -51.0% | 577,548 | -23.8% | 0.01% | -44.4% |
| Q4 2019 | $60,256,000 | +90.3% | 758,037 | +16.2% | 0.02% | +63.6% |
| Q3 2019 | $31,656,000 | -72.6% | 652,444 | -70.3% | 0.01% | -21.4% |
| Q2 2019 | $115,732,000 | +170.2% | 2,200,208 | +171.9% | 0.01% | -22.2% |
| Q1 2019 | $42,831,000 | +46.3% | 809,200 | +13.5% | 0.02% | +63.6% |
| Q4 2018 | $29,267,000 | +9.2% | 712,968 | +1.1% | 0.01% | +22.2% |
| Q3 2018 | $26,806,000 | -65.6% | 705,424 | -59.1% | 0.01% | -67.9% |
| Q2 2018 | $77,916,000 | +174.7% | 1,723,809 | +193.5% | 0.03% | +154.5% |
| Q1 2018 | $28,366,000 | -18.4% | 587,300 | -33.5% | 0.01% | -15.4% |
| Q4 2017 | $34,758,000 | +445.3% | 883,324 | +330.3% | 0.01% | +550.0% |
| Q3 2017 | $6,374,000 | -20.5% | 205,300 | -29.9% | 0.00% | -33.3% |
| Q2 2017 | $8,013,000 | -69.6% | 293,000 | -59.1% | 0.00% | -78.6% |
| Q1 2017 | $26,397,000 | +2553.0% | 716,330 | +941.2% | 0.01% | – |
| Q4 2016 | $995,000 | -69.6% | 68,800 | -51.5% | 0.00% | -100.0% |
| Q3 2016 | $3,273,000 | +38.5% | 142,000 | -0.3% | 0.00% | 0.0% |
| Q2 2016 | $2,363,000 | +798.5% | 142,395 | +757.8% | 0.00% | – |
| Q1 2016 | $263,000 | -42.8% | 16,600 | +52.1% | 0.00% | – |
| Q3 2015 | $460,000 | – | 10,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |